Lag3 blockade enhances the anti-tumor effect of dual GITR agonism and PD-1 blockade in a preclinical melanoma model

被引：0
|
作者：
Maniyar, Rachana R.
Elhanati, Yuval
Mangarin, Levi
Marouf, Yacine
Ahmed, Ashley
Greenbaum, Benjamin
Wolchok, Jedd
Merghoub, Taha
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4034
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4034
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer
    Zhao, Zihan
    Liu, Siyang
    Sun, Rui
    Zhu, Wenjie
    Zhang, Yulin
    Liu, Tianyao
    Li, Tianhang
    Jiang, Ning
    Guo, Hongqian
    Yang, Rong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [22] Cimetidine enhances PD-1 blockade efficacy in melanoma by regulating PD-L1 expression on tumor
    Lee, B.
    Kim, D.
    Lee, B.
    Lee, J.
    Shin, K.
    Kim, H.
    Ko, H.
    Kim, B.
    Kim, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S217 - S217
  • [23] Anti-tumor activity of cisplatin is enhanced by PD-1 blockade in preclinical models of head and neck squamous cell carcinoma
    Tran, Linda
    Allen, Clint T.
    Park, So-Jin
    Xiao, Roy
    Van Waes, Carter
    Schmitt, Nicole C.
    CANCER RESEARCH, 2017, 77
  • [24] Talilmogene laherparepvec increases the anti-tumor efficacy of the anti PD-1 immune checkpoint blockade
    Piasecki, Julia
    Le, Tiep
    Ponce, Rafael
    Beers, Courtney
    CANCER RESEARCH, 2015, 75
  • [25] NKG2A immune checkpoint blockade enhances the anti-tumor efficacy of PD1/PD-L1 inhibitors in a preclinical model
    Sola, Caroline
    Arnoux, Thomas
    Chanuc, Fabien
    Fuseri, Nicolas
    Rossi, Benjamin
    Gauthier, Laurent
    Leget, Corinne
    Bonnafous, Cecile
    Wagtmann, Nicolai
    Morel, Yannis
    Andre, Pascale
    CANCER RESEARCH, 2016, 76
  • [26] Clinical blockade of PD1 and LAG3 — potential mechanisms of action
    Linh T. Nguyen
    Pamela S. Ohashi
    Nature Reviews Immunology, 2015, 15 : 45 - 56
  • [27] Combined Radiation and PI3Kgd Inhibitor Enhances Anti-Tumor Effect of PD-1 Blockade in Immune-competent Syngeneic Breast Cancer Model
    Han, M. G.
    Jang, B. S.
    Kang, M. H.
    Chang, W. I.
    Kim, I. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S109 - S110
  • [28] PD-L1 blockade enhances anti-tumor efficacy of NK cells
    Oyer, Jeremiah L.
    Gitto, Sarah B.
    Altomare, Deborah A.
    Copik, Alicja J.
    ONCOIMMUNOLOGY, 2018, 7 (11):
  • [29] CD47 BLOCKADE SYNERGIZES WITH PD-1 CHECKPOINT INHIBITOR AND ENHANCES ANTI-TUMOR EFFICACY IN HEPATOCELLULAR CARCINOMA
    Kang, Wonseok
    Kim, Ji-Young
    Yang, Sera
    Kang, Sohee
    Paik, Yong-Han
    HEPATOLOGY, 2019, 70 : 1199A - 1200A
  • [30] Blockade of PD-1 and LAG-3 on CD8+T cells, induced by vaccination, elicits superior anti-tumor efficacy
    Zahm, Christopher
    McNeel, Douglas
    Delmastro, Laurne
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345